JNJ - Risk

Solid Quality Asset with Moderate Fluctuation

Healthy balance: Exemplary business financials (Health Score: 85/100) paired with moderate price swings for a single equity (±17.7% p.a.). The score (5/7) reflects the standard baseline for equities under SRI rules.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

5/7 Elevated

5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.2x).

Beta (Market Relation)

0.21x

Defensive

Volatility (5Y p.a.)

17.7% p.a.

5-Year Horizon

Max Drawdown (5Y)

-23.6%

5-Year Horizon

Sharpe Ratio

0.41

Return / Risk

Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+35.2%
3 Years	18.1%	-15.1%	0.82	+17.4%
5 Years	17.7%	-23.6%	0.41	+9.8%
10 Years	18.9%	-27.8%	0.29	+7.9%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)

Overall Governance Risk

4 ISS Score: 4 / 10

Audit Risk

4 ISS Score: 4 / 10

Board Risk

7 ISS Score: 7 / 10

Short Ratio

3.42